The global autotransfusion systems market size is expected to grow from USD 412.8 million in 2020 to USD 541.6 million by 2026 at a CAGR of 4.6%.
The growth of this market is driven by an increasing number of surgical procedures, an increase in the number of implant procedures, the benefits of autotransfusion replacement, and a shortage of donated blood/allogenic blood.
By type, the market is divided into autotransfusion products & accessories. The autotransfusion products segment had a larger share of the market in 2020. The share of autotransfusion products is projected to grow with the highest CAGR during the forecast period due to the many benefits, which are expected to increase its acceptance in the coming years. These components prevent the transmission of transfusion-related diseases to patients, and they provide more consistent blood transfusions than spontaneous blood transfusions. These benefits may increase the demand for autotransfusion products.
Based on the application, the market is divided into Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Other Procedures. In 2020, the cardiac surgeries segment had the largest share in the market. This segment is expected to grow with the highest CAGR during the forecasting period due to the greater prevalence of cardiovascular disease and recommendations for autologous transfusion (by organizations such as WHO) during cardiac surgery.
The report covers markets in all five major regions — North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America held the largest market share in 2020.
Factors such as the increase in cancer in the US and Canada and cancer awareness programs run by local governments and international health organizations in the North American region are key factors driving the market growth.
Some of the leading players operating in the autotransfusion systems market are Becton, Dickinson and Company (US), Medtronic Plc (Ireland), Fresenius (Germany), Zimmer Biomet Holdings, Inc (US), Teleflex Incorporated (US), LivaNova (UK),Beijing ZKSK Technology Co (China), Haemonetics Corporation (US), SARSTEDT (Germany), Atrium Medical Corporation (Sweden),Braile Biomédica (Brazil), Redax (Italy), and Gen World Medical Devices (India).